A History of Innovation Mission & Core Values Notable Facts & Statistics Leadership Our Directory Accreditation Giving Careers at MCPHS University Important Notices Contact

Our Directory


Matthew Silva, PharmD, RPh, BCPS
Professor of Pharmacy Practice

Pharmacy Practice - 421
School of Pharmacy

School of Pharmacy - Worcester/Manchester

Pharmacy (PharmD)


PharmD, Northeastern University

Areas of Teaching
Pharmacy Practice in Family Medicine
Diabetes and Disease Management
Outpatient Cardiology
Physical Assessment
Evidence Based Medicine

Scholarly Interests
Diabetes Prevention and Management
Atherosclerosis and Coronary Artery Disease
Primary and Secondary Prevention
Biostatistics and Meta-Analysis
Outcomes Research and Pharmacoeconomics
Technology in the Classroom

Peer-Reviewed Articles & Book Chapters
Jarvis CI, Seed SM, Silva MA, Sullivan KM. Educational Campaign for Proper Medication Disposal. J Am Pharm Assoc. 2009;49:65-68.

Larochelle PA, Giang DK, Silva MA, Kcomt M, Malloy MJ, Kay S, Ku MT. Post-PharmD Industry Fellowship Opportunities and Proposed Guidelines for Uniformity. AJPE 2009;73:1-9.

Candib LM, Silva M, Cashman SB, Ellstrom D, Mallett K. Creating Open Access to Exercise for Low-income Patients Through a Community Collaboration for Quality Improvement: If You Build It, They Will Come. Journal of Ambulatory Care Management 2008;2:142-150.

Silva MA, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi PJ. Meta-analysis of drug induced adverse events associated with intensive statin therapy. Clin Ther. 2007;29:253-260.

Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: A meta-analysis. Clin Ther. 2006;28:26-35.

Silva MA, Donovan JL, Gandhi PJ, Volturo GA. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both? Vasc Health Risk Manage. 2006; 2(1):39948.

Silva MA, Gandhi PG. Selection of glycoprotein IIb/IIIa inhibitors for upstream use in patients with diabetes experiencing unstable angina or non-ST segment elevation myocardial infarction. What have we learned in the last 10 years? J Clin Pharm Ther. 2005

Chan KY, Boucher ES, Gandhi PJ, Silva MA. HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. Am J Health Syst Pharm. 2004. 61;1676-81.

Silva MA. PDAs in clinical practice: Applications and trends. Hospital Pharmacy Europe (HPE) 2003. 11;75-77

Silva MA, Maas B. Using personal digital assistants to document pharmacist cognitive services and estimate potential reimbursement. Am J Health-Syst Pharm 2003. 60;911-915

Cross J, Donovan JL, Silva MA, Kanaan AO. Pharmacologic management of post-acute coronary syndromes. US Pharm. 2007 32;2:65-78.

Fonseca FA, Izar MC, Silva MA, Karapanos A, Schuster H, Singh D. Invited Commentary; the ARIES Study - Comparison of Efficacy and Safety of Rosuvastatin Versus Atorvastatin in African-American Patients in a Six-Week Trial. Evid Based Cardiovasc Med 2006

Current Professional Memberships, Service & Leadership
Massachusetts Society of Health-System Pharmacists (MSHP)
American Association of Colleges of Pharmacy (AACP)
American College of Clinical Pharmacy (ACCP)
American Society of Health-System Pharmacy (ASHP)

Personal Interests
Computing and medical informatics